papaverine has been researched along with 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 20 (90.91) | 18.7374 |
1990's | 1 (4.55) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (4.55) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
Bristol, JA; Cain, MH; Weishaar, RE | 1 |
Boehme, RE; Gilmer-Waymire, K; Waymire, JC | 1 |
Becker, G; Prasad, KN; Tripathy, K | 1 |
Edström, A; Kanje, M; Löfgren, P; Walum, E | 1 |
Goff, AK; Major, PW | 1 |
Birnbaum, JE; Sapp, TM; Tolman, EL | 1 |
Adachi, K; Numano, F | 1 |
Lederis, K; Mathison, R | 1 |
Amato, RS; Leuschen, MP | 1 |
Duell, EA; Rusin, LJ; Voorhees, JJ | 1 |
Prasad, KN; Sakamoto, A | 1 |
Prasad, KN | 1 |
Kumar, S; Prasad, KN | 1 |
Gross, SR; Longshore, MA; Mayer, SE | 1 |
Blanchard, DK; Djeu, JY; Krzanowski, JJ; Polson, JB; Robicsek, SA; Szentivanyi, A | 1 |
Holtzman, SG | 1 |
Dietz, J; Kaiser, G; Palm, D; Reinhardt, M; Wellstein, A; Wiemer, G | 1 |
Sass, SP; Sheppard, H; Tsien, WH | 1 |
Hidaka, H; Manganiello, VC; Osborne, JC; Vaughan, M; Yamamoto, S; Yamamoto, T | 1 |
Anderson, DW; Crowle, AJ | 1 |
Kedia, GT; Kuczyk, MA; Merseburger, AS; Polat, H; Ückert, S | 1 |
1 review(s) available for papaverine and 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone
Article | Year |
---|---|
A new generation of phosphodiesterase inhibitors: multiple molecular forms of phosphodiesterase and the potential for drug selectivity.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Blood Platelets; Calmodulin; Cardiotonic Agents; Guinea Pigs; Humans; Hypersensitivity; In Vitro Techniques; Lung Diseases; Myocardium; Platelet Aggregation; Substrate Specificity | 1985 |
21 other study(ies) available for papaverine and 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone
Article | Year |
---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
Concomitant elevation of tyrosine hydroxylase and dopamine beta-hydroxylase by cyclic AMP in cultured mouse neuroblastoma cells.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Bucladesine; Cell Line; Cyclic AMP; Dopamine beta-Hydroxylase; Kinetics; Neoplasm Proteins; Nerve Tissue Proteins; Neuroblastoma; Papaverine; Tyrosine 3-Monooxygenase | 1978 |
Differences and similarities between guanosine 3',5'-cyclic monophosphate phosphodiesterase and adenosine 3',5'-cyclic monophosphate phosphodiesterase activities in neuroblastoma cells in culture.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Buffers; Cell Fractionation; Cells, Cultured; Clone Cells; Cyclic GMP; Deoxyribonucleases; Humans; Mice; Neuroblastoma; Papaverine; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Proteins; Ribonucleases; Theophylline | 1975 |
Drug-induced alterations in morphology and level of cAMP in cultured human glioma cells.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adenine; Catecholamines; Cell Line; Cyclic AMP; Cyclic GMP; Dimethyl Sulfoxide; Epinephrine; Glioma; Isoproterenol; Neurons; Papaverine; Phenoxybenzamine; Prostaglandins E; Sotalol; Zeatin | 1975 |
Bovine luteal cyclic AMP and cyclic GMP phosphodiesterase activity; sensitivity to various drugs and hormones.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Cattle; Corpus Luteum; Cyclic AMP; Female; Hormones; Imidazoles; Indomethacin; Kinetics; Papaverine; Phosphoric Diester Hydrolases; Prostaglandins; Theophylline | 1976 |
Cyclic AMP-phosphodiesterase and epidermal mitosis.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Biphenyl Compounds; Bufexamac; Etazolate; Glycyrrhiza; Hydroxamic Acids; Indomethacin; Male; Mice; Mice, Inbred C3H; Mitosis; Papaverine; Phosphodiesterase Inhibitors; Plant Extracts; Plants, Medicinal; Skin; Theophylline | 1976 |
Phosphodiesterase inhibitors: their comparative effectiveness in vitro in various organs.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Aorta; Blood Platelets; Brain; In Vitro Techniques; Liver; Mice; Muscles; Myocardium; Papaverine; Phosphodiesterase Inhibitors; Phthalazines; Rats; Skin; Theophylline | 1977 |
Inhibitory effects of cyclic AMP on vasopressin release from the rat neural lobe in vitro.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Bucladesine; Caffeine; Cyclic AMP; Dose-Response Relationship, Drug; Etazolate; In Vitro Techniques; Male; Papaverine; Pituitary Gland; Rats; Vasopressins; Xanthines | 1977 |
The role of cyclic nucleotides in the regulation of mitotic activity in SSPE virus-infected human brain tissue.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Bucladesine; Cell Line; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Imidazoles; Mitosis; Papaverine; Theophylline | 1978 |
Papaverine and Ro 20-1724 inhibit cyclic nucleotide phosphodiesterase activity and increase cyclic AMP levels in psoriatic epidermis in vitro.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Cyclic AMP; Epidermis; Humans; Imidazoles; In Vitro Techniques; Papaverine; Psoriasis | 1978 |
Effect of sodium butyrate in combination with prostaglandin E1 and inhibitors of cyclic nucleotide phosphodiesterase on human amelanotic melanoma cells in culture.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Butyrates; Cell Count; Cell Division; Cell Line; Cell Survival; Drug Interactions; Humans; Melanoma; Neoplasms, Experimental; Papaverine; Prostaglandins E; Theophylline | 1978 |
Effect of sodium butyrate in combination with X-irradiation, chemotherapeutic and cyclic AMP stimulating agents on neuroblastoma cells in culture.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Antineoplastic Agents; Butyrates; Cell Line; Cyclic AMP; Mice; Neuroblastoma; Papaverine; Prostaglandins E; Radiation Effects; Theophylline | 1979 |
Role of cyclic AMP in differentiation of human neuroblastoma cells in culture.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Bucladesine; Butyrates; Cell Differentiation; Cell Line; Cell Survival; Cyclic AMP; Cyclic GMP; Humans; Imidazoles; Neuroblastoma; Papaverine; Prostaglandin Antagonists; Prostaglandins E; Radiation Effects; Theophylline; Tyrosine 3-Monooxygenase | 1975 |
Stimulation of glycogenolysis by beta adrenergic agonists in skeletal muscle of mice with the phosphorylase kinase deficiency mutation (I strain).
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Epinephrine; Glycogen; Isoproterenol; Male; Mice; Mice, Inbred Strains; Muscles; Papaverine; Phosphorylase Kinase; Phosphorylases; Propranolol; Stimulation, Chemical | 1976 |
Multiple high-affinity cAMP-phosphodiesterases in human T-lymphocytes.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Cell Fractionation; Cyclic GMP; Flow Cytometry; Humans; Isoenzymes; Lymphocyte Activation; Papaverine; Pyridazines; T-Lymphocytes | 1991 |
Phosphodiesterase inhibitors potentiate opiate-antagonist discrimination by morphine-dependent rats.
Topics: 1-Methyl-3-isobutylxanthine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Body Weight; Discrimination, Psychological; Dose-Response Relationship, Drug; Drug Synergism; Male; Morphine; Naltrexone; Narcotic Antagonists; Papaverine; Phosphodiesterase Inhibitors; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Substance-Related Disorders | 1989 |
Desensitization of the beta-adrenoceptor-adenylate cyclase system of immature erythrocytes by in-vivo treatment of rats with isoprenaline.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adenylyl Cyclases; Adrenergic beta-Agonists; Animals; Cyclic AMP; Dihydroalprenolol; Dose-Response Relationship, Drug; Erythrocytes; Isoproterenol; Male; Papaverine; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Adrenergic, beta | 1981 |
The lack of correlation between inhibition of aggregation and cAMP levels with canine platelets.
Topics: 1-Methyl-3-isobutylxanthine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Alprostadil; Animals; Arachidonic Acids; Cyclic AMP; Depression, Chemical; Dogs; Epinephrine; Female; Male; Papaverine; Phosphodiesterase Inhibitors; Platelet Aggregation; Prostaglandins E; Theophylline | 1982 |
Complex effects of inhibitors on cyclic GMP-stimulated cyclic nucleotide phosphodiesterase.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-GMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Cattle; Dipyridamole; Hydrolysis; Kinetics; Liver; Papaverine; Quinolines; Quinolones; Theophylline | 1983 |
Regression and differentiation of neuroblastoma tumors in mice treated with differentiating agents--prostaglandin E1 and a phosphodiesterase inhibitor, RO 20-1724.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Alprostadil; Animals; Cell Differentiation; Drug Therapy, Combination; Female; Imidazoles; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Neuroblastoma; Papaverine; Prostaglandins E | 1982 |
Evaluating the significance of cyclic adenosine monophosphate-mediated signaling in human prostate: a functional and biochemical study.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Aged; Benzamides; Colforsin; Cyclic AMP; Humans; In Vitro Techniques; Inhibitory Concentration 50; Male; Middle Aged; Muscle Contraction; Muscle, Smooth; Papaverine; Phosphodiesterase 4 Inhibitors; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Piperazines; Prostate; Purines; Pyridines; Rolipram; Signal Transduction; Sildenafil Citrate; Sulfones | 2012 |